Review: Methods of synthesis of erlotinib and its derivatives as tyrosine kinase inhibitor in 2020-2025. jpsr [Internet]. 2026 Jan. 1 [cited 2026 May 10];9(1):12-30. Available from: https://www.jport.co/index.php/jport/article/view/361